These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3738860)

  • 1. Soluble fibrinogen derivatives generated by thrombin: affinity for elastin.
    Rabaud M; Lefebvre F; Piquet Y; Belloc F; Chevaleyre J; Roudaut MF; Bricaud H
    Thromb Res; 1986 Jul; 43(2):205-11. PubMed ID: 3738860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adduct formation between soluble fibrin monomers and elastin.
    Rabaud M; Lefebvre F; Martin MT; Aprahamian M; Schmitthaeusler R; Cazenave JP
    Biomaterials; 1987 May; 8(3):217-22. PubMed ID: 2886158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical study of adduct synthesis between fibrin monomers and elastin.
    Martin MT; Lefebvre F; Rabaud M; Graves PV
    Biomaterials; 1988 Nov; 9(6):519-24. PubMed ID: 3224139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sodium citrate in the dysfibrinogenaemia of liver disease.
    Francis JL; Watson NJ; Simmonds VJ
    Thromb Res; 1984 May; 34(3):187-97. PubMed ID: 6729777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
    Smith GF
    Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fibrin-fibrinogen complexes as intermediates in fibrin gel formation.
    Wilf J; Minton AP
    Biochemistry; 1986 Jun; 25(11):3124-33. PubMed ID: 3730352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc modulates thrombin adsorption to fibrin.
    Hopmeier P; Halbmayer M; Fischer M; Marx G
    Thromb Res; 1990 May; 58(3):293-301. PubMed ID: 2353341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thrombin-fibrinogen interaction.
    Scheraga HA
    Biophys Chem; 2004 Dec; 112(2-3):117-30. PubMed ID: 15572239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
    Mosesson MW
    Thromb Haemost; 2003 Jan; 89(1):9-12. PubMed ID: 12540947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.
    Blombäck B; Carlsson K; Fatah K; Hessel B; Procyk R
    Thromb Res; 1994 Sep; 75(5):521-38. PubMed ID: 7992253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (IV). Effects of heparin and its analogues.
    Sato H; Nakajima A; Shimohira T
    Thromb Res; 1985 Sep; 39(5):549-57. PubMed ID: 4082100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen.
    Ly B; Kierulf P; Jakobsen E; Gravem K
    Thromb Res; 1974 Jul; 5(1):21-32. PubMed ID: 4428469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.